Showing results (2391-2400 of 2,553) with videos related to

Sort By:
Pageof 256
The Lancet. Oncology|August 30, 2024
The oncological role of resection in newly diagnosed diffuse adult-type glioma defined by the WHO 2021 classification: a Review by the RANO resect groupPhilipp Karschnia, Jasper K W Gerritsen, Nico Teske, et al.
British Journal of Cancer|March 2, 2013
Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201)Y-K Kang, H-M Chang, J H Yook, et al.
Nature Chemical Biology|May 22, 2019
Small-molecule control of antibody N-glycosylation in engineered mammalian cellsMichelle M Chang, Leonid Gaidukov, Giyoung Jung, et al.
Journal of Neurosurgery|December 22, 2009
Poor drug distribution as a possible explanation for the results of the PRECISE trialJohn H Sampson, Gary Archer, Christoph Pedain, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 8, 2020
The risk of anti-osteoporotic agent-induced severe cutaneous adverse drug reactions and their association with HLAC-B Chen, Y-E Chen, M-T Chu, et al.
The Lancet. Oncology|January 6, 2018
Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working groupBrian M Alexander, Paul D Brown, Manmeet S Ahluwalia, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
A phase I trial of tipifarnib with radiation therapy, with and without temozolomide, for patients with newly diagnosed glioblastomaPhioanh Leia Nghiemphu, Patrick Y Wen, Kathleen R Lamborn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2021
Glioblastoma Clinical Trials: Current Landscape and Opportunities for ImprovementStephen J Bagley, Shawn Kothari, Rifaquat Rahman, et al.
Neuro-Oncology|February 13, 2010
A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomasJeffrey J Raizer, Lauren E Abrey, Andrew B Lassman, et al.
JAMA Ophthalmology|November 14, 2024
Performance of Polygenic Risk Scores for Primary Open-Angle Glaucoma in Populations of African DescentJennifer M Chang-Wolf, Tyler G Kinzy, Sjoerd J Driessen, et al.
Pageof 256